Remicade
Clinic-Embedded Pharmacists Bridge The Biosimilars Gap
Although biosimilars have been available for infliximab (Remicade, Janssen) for approximately five years, uptake ...
SEPTEMBER 2, 2022
Ixifi, a Biosimilar for RA, Receives Approval
FDA approves another biosimilar for Remicade. Ixifi has all of the same indications.
DECEMBER 15, 2017
FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 24, 2017
New Noninferiority Data for Biosimilar Infliximab
Biosimilar infliximab is not inferior to the originator product, Remicade in treating rheumatoid arthritis and ...
OCTOBER 20, 2016
Load more